The second possibility is that Covid has now settled into a rut, which will see it become progressively milder until it ultimately becomes akin to the common cold. Chin-Hong says that this would make ...

An image that is spreading widely online claims that Moderna had created its COVID-19 vaccine two years before the pandemic ...

Renowned computational biologist Janet Thornton discusses the potential of protein structure understanding in developing new ...

Five years after SARS-CoV-2 first surfaced in Wuhan, China, researchers are still trying to understand long COVID. In this ...

It started as a respiratory illness—or so everyone thought. But it quickly became apparent that SARS-CoV-2, the virus that ...

A new experimental vaccine could offer protection not only against many variants of SARS-CoV-2, but also other sarbecoviruses that could spill over from animals to humans.

A UK study finds detectable antibodies reduce COVID-19 infection and severity in immunosuppressed individuals, highlighting ...

The video shows two segments: one featuring commentary about a substance binding to the coronavirus surface, followed by a narration discussing vaccine spike protein structure and antibody responses.

To counteract these challenges, novel strategies aim to restore the cancer immunity cycle. One approach involves directly injecting unadjuvanted influenza vaccines or drug-loaded oncolytic viruses ...

The following is a summary of “Seroprevalence against SARS-CoV-2 after booster vaccination in a prison in Alicante (Spain),” published in the January 2025 issue of Infectious Disease by Montagud et al ...

Announcing a new article publication for BIO Integration journal. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), first identified in China in December 2019, rapidly spread worldwide, ...